ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,996.66
      1.00%
      US Tech 100
      20,877.20
      1.72%
      Dow Jones
      43,487.83
      0.78%
      Brent Oil
      80.005
      0.00%
      Bitcoin
      103,945.04
      -0.17%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Penumbra Inc (PEN)

      7. Penumbra Inc (PEN) News

      Penumbra Inc

      Penumbra Inc (PEN)

      Peninsula Energy Ltd
      Pennant International Group Plc
      PBF Energy Inc
      263.69
      1.38
      (0.53%)
      Closed January 18 4:00PM
      Delayed by 15 minutes
      263.69
      0.00
      (0.00%)
      After Hours: 5:30PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      PEN News

      Official News Only

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      January 06 2025
      PEN (0.53%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      January 06 2025
      PEN (0.53%)

      Form 144 - Report of proposed sale of securities
      Edgar (US Regulatory)
      January 03 2025
      PEN (0.53%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      December 27 2024
      PEN (0.53%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      December 23 2024
      PEN (0.53%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      December 17 2024
      PEN (0.53%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      December 17 2024
      PEN (0.53%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      December 17 2024
      PEN (0.53%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      December 03 2024
      PEN (0.53%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      December 03 2024
      PEN (0.53%)

      Form 144 - Report of proposed sale of securities
      Edgar (US Regulatory)
      December 02 2024
      PEN (0.53%)

      Form 144 - Report of proposed sale of securities
      Edgar (US Regulatory)
      November 29 2024
      PEN (0.53%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      November 22 2024
      PEN (0.53%)

      Form 144 - Report of proposed sale of securities
      Edgar (US Regulatory)
      November 20 2024
      PEN (0.53%)

      PEN Discussion

      View Posts
      @LaughinPaulRyan @LaughinPaulRyan 4 years ago
      ... ALL NEWS IS GOOD? ... $PEN



      CNBC's Scott Wapner reports on why Quintessential Capital Management is shorting Penumbra and why it's questioning the safety of its medical devices.

      👍️0
      @LaughinPaulRyan @LaughinPaulRyan 4 years ago
      QCM legal team filed detailed reports with allegations of misconduct with FDA, SEC and other institutions urging thorough investigation
      Deceptive behavior would point to lack of integrity unworthy of management leading $10bn healthcare company and may explain Jet7 crisis leading to multiple deaths, injuries
      QCM calls on Adam Elsesser, Arani Bose to resign at once if allegations confirmed
      Situation constitutes existential threat to Penumbra’s viability as a public company
      👍️0
      @LaughinPaulRyan @LaughinPaulRyan 4 years ago
      Executive Summary

      Large portion of scientific literature produced by Penumbra appears authored by fake character in sophisticated, multi-year deception
      Fake character seems fabricated by Penumbra’s management attempting to hide involvement in research with significant undisclosed conflicts of interest
      Conflicted research used extensively to market products to healthcare providers, to support FDA applications and to promote stock in IPO
      Legal advisers: behavior, if confirmed, may constitute serious fraud threatening revocation of FDA clearances, SEC enforcement and litigation from clients
      👍️0
      davidsson10 davidsson10 4 years ago
      https://www.qcmfunds.com/penumbra-and-its-killer-catheter/?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link
      👍️0
      @LaughinPaulRyan @LaughinPaulRyan 4 years ago
      ... ROFLMFAO ... $PEN

      Penumbra Inc
      Penumbra, Inc. designs, develops, manufactures, and markets medical devices. The Company offers peripheral vascular and neurovascular devices that help patients suffering from stroke and other neurovascular diseases. Penumbra operates in the United States.
      CURRENT PRICE

      PEN:US197.48USD-26.54-11.85%AS OF 10:55 AM EST 12/08/2020
      👍️0
      TREND1 TREND1 9 years ago
      IPO INFO

      http://www.marketwatch.com/tools/ipo-calendar
      👍️0
      TREND1 TREND1 9 years ago
      IPO NOW HAS SYMBOL
      Penumbra PEN
      👍️0
      TREND1 TREND1 9 years ago
      IPO should be out soon.
      no symbol yet.
      👍️0

      Your Recent History

      NYSE
      PEN
      Penumbra
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads